ENTHEOGENS, MYSTICISM, AND NEUROSCIENCE
Zygon® August 26, 2014 DOI: 10.1111/zygo.12110 via OpenAlex
Summary
AI-generated from the abstractPsychedelic drugs like LSD and psilocybin reliably produce mystical experiences, enabling brain research during such states. Key questions remain: whether drug-occasioned mystical experiences are neurologically identical to traditional mystical states, and whether they differ phenomenologically and theologically. As research progresses and public awareness grows, religious scholars and science-and-religion experts will be needed to interpret the philosophical and theological presuppositions underlying this work and the meaning of its findings.
Study at a glance
| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | Mysticism Psilocybin |
| Keywords | Presupposition Epistemology Psychology |
| Citations | 11 |
| Key finding | Entheogens reliably occasion mystical experiences, raising questions about neurological, phenomenological, and theological differences from traditional mystical states. |
Abstract
Entheogens or psychedelic drugs such as lysergic acid diethylamide (LSD) and psilocybin are associated with mystical states of experience. Drug laws currently limit research, but important new work is under way at major biomedical research facilities showing that entheogens reliably occasion mystical experiences and thereby allow research into brain states during these experiences. Are drug‐occasioned mystical experiences neurologically the same as more traditional mystical states? Are there phenomenological and theological differences? As this research goes forward and the public becomes more widely aware of its achievements, religious scholars and experts in science and religion will be called upon to interpret the philosophical and theological presuppositions that underpin this research and the significance of the findings that flow from it.